{
"NDC": {
"NDCCode": "73141-104-42",
"PackageDescription": "42 CUP, UNIT-DOSE in 1 CARTON (73141-104-42) / 5 mL in 1 CUP, UNIT-DOSE (73141-104-05) ",
"NDC11Code": "73141-0104-42",
"ProductNDC": "73141-104",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Atovaquone",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Atovaquone",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20241129",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA212918",
"LabelerName": "A2A Integrated Pharmaceuticals, LLC",
"SubstanceName": "ATOVAQUONE",
"StrengthNumber": "750",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Antimalarial [EPC], Antiprotozoal [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-01-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20241129",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}